Scan to downloadCHUGAI PHARMACEUTICAL CO., LTD. (4519) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-10-27 | Earnings Release | CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the nine months ended September 30, 2026) | |
| 2026-10-27 | Earnings Release | Supplementary Materials Consolidated Financial Statements for the nine months ended September 30, 2026 (IFRS) | |
| 2026-10-22 | — | F. Hoffmann-La Roche Announces Third Quarter Sales 2026 | |
| 2026-09-28 | — | Notice Regarding Discontinuation of Development of GYM329 (emugrobart) for Obesity, Return of License and Resumption of Development for SMA | |
| 2026-07-24 | Earnings Release | CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2026) | |
| 2026-07-24 | Earnings Release | Supplementary Materials Consolidated Financial Statements for the six months ended June 30, 2026 (IFRS) | |
| 2026-07-23 | — | F. Hoffmann-La Roche Announces Half Year Results 2026 |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.